-+ 0.00%
-+ 0.00%
-+ 0.00%

ABELZETA RECEIVES FDA CLEARANCE OF REGISTRATIONAL PHASE II TRIAL FOR C-CAR168 IN REFRACTORY LUPUS NEPHRITIS

Reuters·07/27/2026 13:05:59

Please log in to view news